Your browser doesn't support javascript.
loading
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer.
Harvey, Jennet M; Clark, Gary M; Osborne, C Kent; Allred, D Craig.
Affiliation
  • Harvey JM; From the Department of Pathology, University of Western Australia, Nedlands, Western Australia, Australia; and Division of Medical Oncology and Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX.
  • Clark GM; From the Department of Pathology, University of Western Australia, Nedlands, Western Australia, Australia; and Division of Medical Oncology and Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX.
  • Osborne CK; From the Department of Pathology, University of Western Australia, Nedlands, Western Australia, Australia; and Division of Medical Oncology and Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX.
  • Allred DC; From the Department of Pathology, University of Western Australia, Nedlands, Western Australia, Australia; and Division of Medical Oncology and Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX.
J Clin Oncol ; 41(7): 1331-1338, 2023 03 01.
Article in En | MEDLINE | ID: mdl-36827742
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Country of publication: